FOR VETERINARY USE ONLY (US) 
Pseudorabies Vaccine, Modified Live Virus
For the immunization of healthy pigs 3 days of age or older against pseudorabies, including the respiratory form of the disease.
ADVANTAGES:
- Genetically designed. Permits serologic differentiation between vaccinates and field infected animals.
- Either gI or gX testing can be used with PRV/Marker Gold.
- Long-lasting protection against clinical and subclinical pseudorabies, including respiratory disease.
- Shuts down virus shedding and disease spread within the herd.
- Convenient IM (intramuscular) or IN (intranasal) administration.
- Proven safety in pigs, even in 3-day-old pigs, and your feeder pigs.
- Proven safe in gilts and sows at any stage of pregnancy.
|
|
|
|
|
 |
 |
Description
PRV/Marker Gold is a genetically designed, live virus vaccine for the immunization of healthy pigs against pseudorabies (Aujeszky. s disease). Specific genetic modifications have been made in the vaccine virus to optimize safety and efficacy, and to allow serologic differentiation based on either gI or gX deletions.
Indications
For the immunization of healthy pigs 3 days of age or older against pseudorabies, including the respiratory form of the disease.
Dosage and Administration
For use in swine only. Aseptically rehydrate PRV/Marker Gold with diluent supplied. Administer 2 ml intramuscularly or intranasally. Pigs nursing non-immune dams may be safely and effectively vaccinated at 3 days of age or older. Pigs nursing immune dams should be vaccinated when maternal antibody levels will allow active immunization. Semi-annual revaccination is recommended for pigs retained for breeding. Sows may be safely vaccinated at any stage of pregnancy.
Caution
Do not vaccinate within 21 days of slaughter. Store at 35°-45°F (2°-7°C). Use entire contents without delay after rehydration. Burn container and all unused contents. Contains gentamicin as a preservative. Anaphylactoid reactions may occur. Antidote: Epinephrine.
Note
Vaccination with PRV/Marker Gold will yield seropositive results in nondifferentiating SN, ELISA and latex agglutination tests. Distribution is limited to individuals designated by authorized officials, under such conditions as these authorities may require.
How Supplied
10, 25, 50 and 100 dose vials.
Disclaimer: Every effort has been made to ensure the accuracy of the information published. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the product label or package insert.
|
|
